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Although several studies have examined the relationship between intimate partner violence (IPV) 
and drug use among women in drug treatment programs, more information is needed to delineate 
differences, as a function of the specific drug used. Data from a random sample of 416 women 
attending methadone programs were analyzed to elucidate the differential associations between 
IPV and use of the following: marijuana only, cocaine only, heroin  only, or cocaine and heroin. 
Prevalence of IPV among this sample far exceeded estimates from the general population. After 
adjusting for sociodemographic variables, use of cocaine only was significantly associated with 
an increased likelihood of experiencing IPV compared with no drug use. Similar results were 




Recognition of intimate partner violence (IPV) as a significant public health problem for women 
in drug treatment has emerged over the last decade. Past-year prevalence rates of IPV among 
women in drug treatment have been found to range between 25% and 57% (Brewer, Fleming, 
Haggerty, & Catalano, 1998; Chermack, Fuller, & Blow, 2000; El-Bassel, Gilbert, Wada, Witte, 
& Schilling, 2000). These rates of received IPV are substantially higher than the range of 1.5% 
to 16% prevalence rates found in epidemiological surveys of community-based samples 
(Caetano, Nelson, & Cunradi, 2001; Tjaden & Thoennes, 1998). Furthermore, a growing body of 
evidence suggests that interpersonal stress and relationship conflict are major triggers for relapse 
among women in drug treatment (Leshner, 1998; McKay, Rutherford, Cacciola, Kabasakalian-
McKay, & Alterman, 1996) and that IPV may result in continued drug use, relapse, and attrition 
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from drug treatment among women (Gilbert, El-Bassel, Rajah, Foleno, & Frye, 2001; Gil-Rivas, 
Fiorentine, Anglin, & Taylor, 1997; Melchior, Huba, Brown, & Slaughter, 1999). 
 
This study addresses some of the critical gaps in knowledge on the prevalence of IPV and on the 
relationship between drug use and IPV among women in drug treatment. In this study we (a) 
describe the prevalence rates of different types of IPV (i.e., physical, sexual, and injurious) in the 
past 6 months and lifetime; (b) describe univariate associations between sociodemographic and 
drug use factors and experience of IPV; (c) examine the differential associations between 
women's drug use and IPV, depending on type of drug(s) women used—marijuana only, crack 
cocaine only, heroin only, or both crack cocaine and heroin—and their experience of different 





Random Sampling and Recruitment Procedures 
 
We randomly selected 753 women from the total population of women who were enrolled in 14 
methadone maintenance treatment clinics in New York City. Eligibility criteria for this study 
were being female and between the ages of 18 and 55; being in methadone maintenance 
treatment for at least 3 months; and during the past year, having had a sexual or dating 
relationship with someone whom the woman described as her boyfriend, girlfriend, spouse, 
regular sexual partner, or the father of her children. 
 
A total of 559 women agreed to participate in a 15-min screening interview, and 427 met 
eligibility criteria. Of those eligible, 416 (97%) women agreed to participate. All participants 
signed a consent form that detailed confidentiality procedures and their rights as research 
participants. The Institutional Review Boards of the participating methadone maintenance 
treatment programs (MMTPs) and Columbia University (the research institution) approved the 
protocol for this study. Participants were compensated $5 for completing the screening interview 




Trained interviewers conducted face-to-face structured interviews with participants. The baseline 
questionnaire assessed socio-demographic information, including age, ethnicity, level of 
education, marital status, having more than one partner, and current employment status. 
 
We assessed drug use with the Drug Use and Risk Behavior Questionnaire (El-Bassel, Ivanoff, 
Schilling, Gilbert, & Chen, 1995). This questionnaire assesses frequency of heroin, crack, 
cocaine, and marijuana use in the prior 6 months with a 6-point Likert scale. 
 
We also inquired about IPV experienced in the prior 6 months as well as lifetime, using the 
Minor and Severe Physical Assault, Sexual Coercion, and Injury Scales of the Revised Conflict 









Women who reported experiencing one or more abusive acts by an intimate partner on the Minor 
and Severe Physical Assault, Injury, or Sexual Coercion subscales of the Revised Conflicts 
Tactics Scale in the past 6 months were considered ―recently abused‖ (n = 193). Women who 
indicated that they had experienced IPV on these subscales in the past, but not in the past 6 
months, and women who never experienced IPV, were considered ―non-recently abused‖ (n = 
223). 
 
We compared recently abused versus non-recently abused women, using univariate logistic 
regression analysis to estimate unadjusted odds ratios (ORs) and 95% confidence intervals (CIs) 
for the sociodemographic and drug use factors associated with recent IPV. 
 
We used logistic regression analyses to examine whether women's use of marijuana, crack 
cocaine, and/or heroin in the past 6 months was associated with different types of IPV after 
adjusting for potentially confounding sociodemographic variables (i.e., age, education, marital 
status, ethnicity, and having more than one intimate partner in the past year), which were 
selected on the basis of whether previous research indicated a relationship with IPV (Caetano et 
al., 2001; Chermack, Walton, Fuller, & Blow, 2001). 
 
In this logistic regression model, sociodemographic background variables are entered with four 
mutually exclusive drug use type categories for women: (a) marijuana only—marijuana use in 
the past 6 months, but not crack cocaine or heroin; (b) crack cocaine only—crack cocaine use in 
the past 6 months, but not heroin; (c) heroin only—heroin use in the past 6 months, but not crack 
cocaine; and (d) crack cocaine and heroin—heroin and crack cocaine use in the past 6 months. 
Participants who used marijuana in combination with crack cocaine or heroin in the past 6 
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months were categorized according to their use of crack cocaine and heroin. The reference group 
for the drug use variable is women who reported no use of marijuana, crack cocaine, or heroin in 
the past 6 months. Our rationale for the use of these specific drugs is based on previous research 
that found high rates of crack cocaine use in combination with heroin use, as well as significant 
rates of marijuana use among women in MMTPs (Brewer et al., 1998; El-Bassel et al., 1998). 
These mutually exclusive drug use categories may accommodate for the identification of 
differential associations between IPV and drug use based on the specific drug used by women. 
 
Two women did not provide self-reported IPV data. For regression analyses, we used multiple 
imputation to deal with missing data. We performed the multiple imputation using Amelia for 




Prevalence of IPV 
 
Prevalence of different types of IPV in the past 6 months and lifetime are reported in Table 1. 
Among the 414 women who provided self-reported IPV data, 88% reported sustaining an injury 
or experiencing at least one incident of physical or sexual IPV in their lifetime. Almost three 
quarters (73%) of the women indicated that they had experienced severe injurious, physical, or 
sexual IPV in their lifetime. About one half (47%) of the women reported injurious, physical, or 
sexual IPV in the past 6 months, and about one-fifth (19%) indicated that they had experienced 
severe physical or sexual IPV or had sustained a severe injury by an intimate partner in the past 6 
months. The prevalence estimates of received IPV broken down by type, severity, and time 




The mean age of the women was 39.9 years (SD = 6.7 years), 20% were married, and 21% had 
had more than one sexual partner in the past year. The majority were Latina (48%, n = 198) or 
African American (32%, n = 128). More than half (58%, n = 240) had completed high school. 
 
Bivariate logistic regression analyses of the data indicated that any physical, sexual, or injury-
related IPV in the past 6 months was associated with being a high school graduate (OR = 1.7, 
95% CI: 1.0, 2.8), never married (OR = 1.7, 95% CI: 1.0, 3.0) and having more than one intimate 
partner in the past year (OR = 3.0, 95% CI: 1.8, 5.0). Recently abused women were less likely 
than their counterparts to be White (OR = 0.58, 95% CI = 0.35, 0.98). 
Current Drug Use 
 
Thirty-eight percent of the women reported using heroin in the past 6 months, 40% reported 
using crack cocaine, and one quarter (25%) reported using marijuana. One quarter (25%) 
reported using both crack cocaine and heroin. 
Relationship Between Type of Drug Used and Type of IPV 
 
Results from analyses regarding the relationships between women's drug use and experiencing 






This table presents the odds ratios for various types of IPV by four mutually exclusive recent 
drug use categories for the women—(a) marijuana only, (b) crack cocaine only, (c) heroin only, 
and (d) crack cocaine and heroin—adjusting for age, ethnicity, marital status, education, and 
having more than one intimate partner. Compared to women who reported no use of illicit drugs, 
women who reported only using crack cocaine were more likely to report experiencing any IPV, 
sexual IPV, and physical IPV in the past 6 months. Women who reported crack cocaine and 
heroin use were also more likely than women who did not use illicit drugs to report experiencing 
any IPV, sexual IPV, physical IPV, and injurious IPV in the past 6 months. No significant 
differences  were observed between women's use of only marijuana or only heroin compared to 




To our knowledge, this is the first study to examine the prevalence of different types of IPV and 
the associations between various types of drug use using a random sample of low-income, urban 
women attending MMTPs. The past 6-month prevalence rates of physical, injurious, or sexual 
IPV among this random sample was as high or higher than the range of past-year prevalence 
rates of IPV found in previous studies of nonrandom samples of women in drug treatment. The 
significant associations between crack cocaine use alone or in conjunction with heroin  and all 
types of IPV suggest that multiple mechanisms may link crack cocaine use and IPV, as indicated 
by the previous research mentioned earlier. The lack of any observed significant associations 
between only using heroin and IPV is also consistent with previous studies (Brewer et al., 1998; 
El-Bassel et al., 2000). Contrary to previous research (Brewer et al., 1998; El-Bassel et al., 
2000), this study did not find any significant associations between marijuana  use and different 
types of IPV. The lack of association found in this study may be a result of not including 
polydrug marijuana users with marijuana-only users. 
 
The causal relationship between IPV and illicit drug use remains unclear in this cross-sectional 
study. Longitudinal studies among women in methadone maintenance treatment, as well as in 
other drug abuse treatment programs, are needed to test causal hypotheses more definitively, that 
is, whether IPV leads to subsequent crack cocaine use, crack cocaine use leads to subsequent 
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IPV, or whether a third factor (e.g., exchange of sex for money or drugs) drives both crack 
cocaine use and IPV. 
 
Although the current study used data from a random sample of women in MMTPS that is larger 
than previous studies, which also typically used nonrandom samples, the findings may not be 
generalizable to other populations of women in drug treatment. In addition, further analyses are 
needed to account better for the frequency of drug use, because associations between drug use 
patterns and IPV may change on the basis of the extent of abuse or addiction to illicit drugs. 
Failure to control for the drug use of the women's partners is another limitation of this study. 
 
Despite these limitations, this study has implications for addressing the co-occurring problems of 
substance abuse and IPV among low-income, urban women in MMTPs. The high prevalence of 
recent and severe IPV among this random sample of women underscores the need to implement 
routine screening for IPV in MMTPs. Failure to identify and prevent IPV among women in drug 
treatment may jeopardize their safety as well as their recovery. 
 
The different associations with IPV by type of drug use found in this study further suggest the 
importance of using a drug-specific approach, rather than a generic approach, to address 
comorbid substance abuse and IPV. Given the limitations on resources and time that often exist 
within methadone treatment programs, enhanced assessment and referral could be targeted 
toward women at higher risk, that is, female patients who need services for both opioid and crack 
cocaine abuse. In addition, standard protocols for assessment, safety planning, treatment, and 
referral to address the co-occurring problem of IPV with different types of drug use, particularly 
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